Arkolith/Insider Trading/ARTV/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerArtiva Biotherapeutics, Inc. (ARTV) · full profile →Form 4 · filed Jun 16, 2026
Net Buying
Open-Market Buys
$4.6M
Open-Market Sells
$0
Net Open-Market Flow
$4.6M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2026Buy(P)125K$8.89$1.1M16.8M
Jun 15, 2026Buy(P)15K$8.99$139K16.6M
Jun 12, 2026Buy(P)391K$8.57$3.4M16.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000656) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML